Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation

Neuropsychopharmacology

Volumn 36, Issue 13, 2011, Pages 2710-2719

  Martinot, Marie Laure Paillère ^a,b   Martinot, Jean Luc ^b,c   Ringuenet, Damien ^d   Galinowski, André ^e   Gallarda, Thierry ^e   Bellivier, Frank ^f   Lefaucheur, Jean Pascal ^g   Lemaitre, Hervé ^b,c   Artiges, Eric ^b,c,h  

^a University Paris Descartes ^*  (France)

^b INSERM   (France)

^c DIF   (France)

^d HÔPITAL PAUL BROUSSE   (France)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h Orsay Hospital   (France)

Author keywords

depression; fluorodeoxyglucose; magnetic resonance imaging; positron emission tomography; transcranial magnetic stimulation; treatment response

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; DEPRESSION; FEMALE; GLUCOSE TRANSPORT; HUMAN; HYPERMETABOLISM; LIMBIC SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; UNCINATE FASCICULUS;

ADULT; AGED; BRAIN; BRAIN DISEASES, METABOLIC; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 80855123793     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.161     Document Type: Article

References (52)

1. Annett M (1970). A classification of hand preference by association analysis. Br J Psychol 61: 303-321.
2. Ashburner J, Friston KJ (2005). Unified segmentation. Neuroimage 26: 839-851. (Pubitemid 40825026)
3. Barrett J, Della-Maggiore V, Chouinard PA, Paus T (2004). Mechanisms of action underlying the effect of repetitive transcranial magnetic stimulation on mood: behavioral and brain imaging studies. Neuropsychopharmacology 29: 1172-1189. (Pubitemid 38670054)
4. Brakemeier EL, Wilbertz G, Rodax S, Danker-Hopfe H, Zinka B, Zwanzger P et al (2008). Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. J Affect Disord 108: 59-70. (Pubitemid 351418014)
5. Brooks 3rd JO, Hoblyn JC, Woodard SA, Rosen AC, Ketter TA (2009). Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. J Psychiatr Res 43: 497-502.
6. Buchbaum MS, Buchbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY et al (2007). Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 164: 1072-1081. (Pubitemid 47121396)
7. Burgmer M, Pogatzki-Zahn E, Gaubitz M, Wessoleck E, Heuft G, Pfleiderer B (2009). Altered brain activity during pain processing in fibromyalgia. Neuroimage 44: 502-508.
8. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S et al (2007). Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 34: 137-143. (Pubitemid 44765265)
9. Chanraud S, Martelli C, Delain F, Kostogianni N, Douaud G, Aubin HJ et al (2007). Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 32: 429-438. (Pubitemid 46106949)
10. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. L Erlbaum Associates: Hillsdale, NJ.
11. Drevets WC (1999). Prefrontal cortical-amygdalar metabolism in major depression. Ann NY Acad Sci 877: 614-637. (Pubitemid 29351882)
12. Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813-829.
13. Drevets WC, Bogers W, Raichle ME (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsycho-pharmacol 12: 527-544. (Pubitemid 35408704)
14. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M et al (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827. (Pubitemid 27181254)
15. Fregni F, Marcolin MA, Myczkowski M, Amiaz R, Hasey G, Rumi DO et al (2006). Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsycho-pharmacol 9: 641-654. (Pubitemid 46127397)
16. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P et al (1995). Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. NeuroReport 6: 1853-1856.
17. Greden JF (2001). The burden of disease for treatment-resistant depression. J Clin Psychiatry 62: 26-31.
18. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
19. Herrmann LL, Ebmeier KP (2006). Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 67: 1870-1876. (Pubitemid 46048184)
20. Hooker CI, Knight RT (2006). The role of the lateral orbitofrontal cortex in the inhibitory control of emotion. In: Zald DH, Rauch SL (eds). The Orbitofrontal Cortex. Oxford University Press: Oxford, 307-324.
21. Hornig M, Mozley PD, Amsterdam JD (1997). HMPAO SPECT brain imaging in treatment-resistant depression. Prog Neuro-psychopharmacol Biol Psychiatry 21: 1097-1114. (Pubitemid 27478854)
22. Houenou J, Wessa M, Douaud G, Leboyer M, Chanraud S, Perrin M et al (2007). Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry 12: 1001-1010. (Pubitemid 350006208)
23. Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE et al (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49: 97-109. (Pubitemid 32119503)
24. Konarski JZ, Kennedy SH, McIntyre RS, Rafi-Tari S, Soczynska JK, Mayberg HS (2007). Relationship between regional brain metabolism, illness severity and age in depressed subjects. Psychiatry Res 155: 203-210. (Pubitemid 47042363)
25. Lam RW, Chan P, Wilkins-Ho M, Yatham LN (2008). Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 53: 621-631.
26. Langguth B, Wiegand R, Kharraz A, Landgrebe M, Marienhagen J, Frick U et al (2007). Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuro Endocrinol Lett 28: 633-638.
27. Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A et al (2009). Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 34: 522-534.
28. Little JT, Ketter TA, Kimbrell TA, Dunn RT, Benson BE, Willis MW et al (2005). Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol Psychiatry 57: 220-228. (Pubitemid 40187365)
29. Loo CK, Mitchell PB (2005). A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 88: 255-267. (Pubitemid 41447523)
30. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239. (Pubitemid 36918259)
31. Martinot JL (1992). Drug washout issues in studies of cerebral metabolism by positron emission tomography in psychiatric patients. J Neural Transm (Suppl) 37: 27-38.
32. Mayberg HS (1997a). Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 9: 471-481. (Pubitemid 27363950)
33. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, McGinnis S et al (1997b). Cingulate function in depression: a potential predictor of treatment response. NeuroReport 8: 1057-1061. (Pubitemid 27152174)
34. Mayberg HS, Lewis PJ, Regenold W, Wagner Jr HN (1994). Paralimbic hypoperfusion in unipolar depression. J Nucl Med 35: 929-934. (Pubitemid 24168118)
35. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389. (Pubitemid 9136500)
36. Mottaghy FM, Keller CE, Gangitano M, Ly J, Thall M, Parker JA et al (2002). Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res 115: 1-14. (Pubitemid 34880095)
37. Nadeau SE, McCoy KJ, Crucian GP, Greer RA, Rossi F, Bowers D et al (2002). Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol 15: 159-175. (Pubitemid 35006771)
38. O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z et al (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62: 1208-1216. (Pubitemid 350060890)
39. Paillère Martinot ML, Galinowski A, Ringuenet D, Gallarda T, Lefaucheur JP, Bellivier F et al (2009). Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [18F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsy-chopharmacol 9: 1-15.
40. Pascual-Leone A, Rubio B, Pallardó F, Catalá MD (1996). Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 347: 233-237. (Pubitemid 26254198)
41. Savitz J, Drevets WC (2009). Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 33: 699-771.
42. Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N et al (2002). Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 59: 250-261. (Pubitemid 34212502)
43. Schmahmann JD, Pandya DN (2006). Uncinate fasciculus. In: Schmahmann JD, Pandya DN (eds). Fiber Pathways of the Brain. Oxford University Press: New York, 419-425.
44. Schultz W, Tremblay L, Hollerman JR (1998). Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37: 421-429. (Pubitemid 28306931)
45. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z et al (2004). Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 22: 409-418. (Pubitemid 38515850)
46. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20): 22-33; quiz 34-57. (Pubitemid 29001829)
47. Talairach J, Tournoux P (1988). Co-Planar Stereotaxic Atlas of the Human Brain: An Approach to Medical Cerebral Imaging. Thieme Medical Publishers: New York.
48. Teneback CC, Nahas Z, Speer AM, Molloy M, Stallings LE, Spicer KM et al (1999). Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 11: 426-435.
49. Thase ME, Rush AJ (1997). When at first you don't succeed: sequential strategies for antidepressant nonresponders. J. Clin. Psychiatry 58(Suppl 13): 23-29. (Pubitemid 28011969)
50. Tyrer P, Owen RT, Cicchetti DV (1984). The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. J Neurol Neurosurg Psychiatry 47: 970-975.
51. Videbech P (2000). PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 101: 11-20. (Pubitemid 30041119)
52. Zald DH (2003). The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Brain Res Rev 41: 88-123. (Pubitemid 36044596)